Children’s Medical Center Dallas (Children’s) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children. Pediatric strokes is a little-known condition that occurs as often as leukemia and brain tumors but often is not recognized by parents or physicians, despite the serious short- and long-term health consequences. As part of this effort, Children’s will be one of four research sites in North America participating in this groundbreaking research.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childrens/48624/
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company’s state-of-the-art research center in Billerica, MA, is LEED® Gold certified under the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED® is the nation’s preeminent program for the design, construction and operation of high performance green buildings. The Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and fertility, and is one of only five laboratories in Massachusetts to achieve this high rating.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/emdserono/49715/
An unprecedented Veterans Affairs (VA) research program that promises to advance the sophisticated science of genomics goes national today. “The Veterans Affairs Research and Development Program has launched the Million Veteran Program, or MVP—an important partnership between VA and Veterans to learn more about how genes affect health, and thus, transform health care for Veterans and for all Americans,” announced VA Under Secretary for Health Robert A. Petzel, MD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/va/48429/
For those in the creative fields, anticipating and adapting to change -- from the tools they’re using at work to the people they’re interacting with to the audiences they’re targeting -- has become part and parcel of the job. A new research guide, The Creative Team of the Future, explores key trends shaping the marketing and design fields, and how industry professionals can prepare for and capitalize on upcoming changes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/roberthalf/50678/
On October 21st, 2011, Lancôme invites customers to experience the “Beauty of Giving” by celebrating Genes Day, a one-day national event Lancôme began in 2010 to support St. Jude Children’s Research Hospital, one of the world’s premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases. On this day, Lancôme will donate $7 from the sale of every bottle of Génifique Youth Activating Concentrate to St. Jude. (This is in addition to special promotions and events nationwide surrounding Genes Day throughout the month of October.)
To view Multimedia News Release, go to http://www.multivu.com/mnr/52300-lancome-genes-day-2011-st-jude-julia-roberts-genifique-beauty-of-giving
Corporate Executive Board (CEB) (NYSE: EXBD), a leading research and advisory services firm, today announced the release of “The Challenger Sale: Taking Control of the Customer Conversation,” a new book that confirms companies are wasting precious time and money cultivating sales people who focus on building and maintaining relationships instead of teaching business insights—the number one attribute customers value in today’s complex selling environment. “The Challenger Sale” prescribes specific steps companies can take to develop a sales force of Challengers, which in a study of more than 6,000 sales reps, consistently outperformed other types of sales reps by nearly 15 percent.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52980-corporate-executive-board-new-book-the-challenger-sale-dixon-adamson
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer.
The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
New research published by Palo Alto Networks™, the network security company, indicates explosive growth in global social networking and browser-based file sharing on corporate networks, with a 300 percent increase in active social networking (e.g., posting, applications) compared with activity during the same period in the latter half of 2010. The Palo Alto Networks Application Usage and Risk Report provides a global view into application usage based on assessments of the raw application traffic from more than 1,600 enterprises between April 2011 and November 2011.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52469-palo-alto-networks-social-networking-applications-growth-research
Doctors at Children’s Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts on Sunday, January 15 during the “Play Without Pain: Children’s Sickle Cell Benefit,” a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children’s Hospital Boston. Held at Caesars Palace, the evening included a performance of Celine Dion’s glamorous show directed by Grammy Awards producer Ken Ehrlich, including a touching tribute to sickle cell victims during her rendition of Billy Joel’s “Lullabye.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/54153-celine-dion-play-without-pain-children-s-sickle-cell-benefit
After the overwhelming success and popularity of the sold-out 2010 inaugural conference, Food for your Whole Life is back this year with an exciting lineup of renowned researchers and experts who will provide attendees with inspiring, insightful ideas and current, necessary information on health. The 2012 Food for your Whole Life health symposium will emphasize the effects of foods and food-based dietary patterns on health for the general population and specific groups while sharing new research and theories on nutrition. Attendees will leave with a sense of empowerment that will enable them to create better environments all around them and ultimately make healthy choices more attainable.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54414-food-for-your-whole-life-health-symposium-new-york-city-2012
